Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment

UNC Libraries(2020)10.17615/yxrk-he83Source: DataRank Database

Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (35)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

G. C. Blobe,J. Chen ORCID,J. Liu,H. Tian,Michael L. Gatza ORCID

Live enrichment

PubMed:20819859 OpenAlex:https://openalex.org/W4298298838

National Institutes of Health

Grant: 1L17MB000231-90

EXCEPTIONAL FINANCIAL NEED SCHOLARSHIP

National Institutes of Health

Grant: 5R01CA135006-04

Role of TbRIII in Regulating Motility and Invasion

National Institutes of Health

Grant: 3R01CA136786-05S1

Function of TbRIII as a BMP Co-receptor in Human Cancer

FWCI

0.00

Citation Percentile

0.2%

greenLicense: Springer TDM

repositoryhttps://doi.org/10.17615/yxrk-he83

https://doi.org/10.1038/onc.2015.13

https://www.nature.com/articles/onc201513.pdf

https://dx.doi.org/10.17615/yxrk-he83

https://pubmed.ncbi.nlm.nih.gov/25823021

Fields of Study

TGF-β signaling in diseases0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

FibulinTransforming growth factorCancer researchBreast cancerCancerTumor microenvironmentMedicineOncologyInternal medicineBiologyCell biologyExtracellular matrixExtracellular Matrix ProteinsMice, Inbred BALB CEpithelial-Mesenchymal TransitionReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IIBreast NeoplasmsProtein Serine-Threonine KinasesArticleNeoplasm ProteinsGene Expression Regulation, NeoplasticMiceTransforming Growth Factor betaCell Line, TumorAnimalsHumansFemaleNeoplasm MetastasisReceptors, Transforming Growth Factor betaSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being